Literature DB >> 24380101

Time to include buprenorphine-naloxone combination in the WHO Model List of Essential Medicines.

Yatan Pal Singh Balhara.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24380101

Source DB:  PubMed          Journal:  J Opioid Manag        ISSN: 1551-7489


× No keyword cloud information.
  7 in total

1.  Patient predictors of substance use disorder treatment initiation in primary care.

Authors:  Allison J Ober; Katherine E Watkins; Colleen M McCullough; Claude M Setodji; Karen Osilla; Sarah B Hunter
Journal:  J Subst Abuse Treat       Date:  2018-04-28

2.  An organizational readiness intervention and randomized controlled trial to test strategies for implementing substance use disorder treatment into primary care: SUMMIT study protocol.

Authors:  Allison J Ober; Katherine E Watkins; Sarah B Hunter; Karen Lamp; Mimi Lind; Claude M Setodji
Journal:  Implement Sci       Date:  2015-05-08       Impact factor: 7.327

3.  Sustaining alcohol and opioid use disorder treatment in primary care: a mixed methods study.

Authors:  Sarah B Hunter; Allison J Ober; Colleen M McCullough; Erik D Storholm; Praise O Iyiewuare; Chau Pham; Katherine E Watkins
Journal:  Implement Sci       Date:  2018-06-18       Impact factor: 7.327

4.  Canadian clinical practice guidelines for the use of plant-based cannabis and cannabinoid-based products in the management of chronic non-cancer pain and co-occurring conditions: protocol for a systematic literature review.

Authors:  Patrick Wright; Zach Walsh; Shari Margolese; Tatiana Sanchez; Stephanie Arlt; Lynne Belle-Isle; Michelle St Pierre; Alan Bell; Paul Daeninck; Marilou Gagnon; Gary Lacasse; Caroline MacCallum; Enrico Mandarino; Janet Yale; James O'Hara; Cecilia Costiniuk
Journal:  BMJ Open       Date:  2020-05-24       Impact factor: 2.692

5.  National List of Essential Medicines in India: A Story of Deprivation of Substance Use Disorder Treatment.

Authors:  Arpit Parmar; Arghya Pal; Pawan Sharma
Journal:  Indian J Psychol Med       Date:  2020-12-07

6.  Cannabis use among opioid-dependent individuals on opioid substitution therapy.

Authors:  Yatan Pal Singh Balhara; Raka Jain
Journal:  J Pharmacol Pharmacother       Date:  2014-07

7.  Assessing and improving organizational readiness to implement substance use disorder treatment in primary care: findings from the SUMMIT study.

Authors:  Allison J Ober; Katherine E Watkins; Sarah B Hunter; Brett Ewing; Karen Lamp; Mimi Lind; Kirsten Becker; Keith Heinzerling; Karen C Osilla; Allison L Diamant; Claude M Setodji
Journal:  BMC Fam Pract       Date:  2017-12-21       Impact factor: 2.497

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.